PARK7 (Parkinson disease protein 7) variants and mutations
PARK7 (also known as Parkinson disease protein 7) is a human protein-coding gene encoding a parkinson disease protein 7 protein. It supports mitochondrial quality control, redox homeostasis, and cellular responses to oxidative stress. Biallelic loss-of-function variants cause a rare autosomal recessive form of early-onset Parkinson disease. This analysis covers 392 PARK7 variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes Young adult-onset Parkinsonism, Parkinson disease, and young-onset Parkinson disease. Example PARK7 variants include A2S, A2T, and A2D.
Variant analysis overview
- Gene: PARK7
- Protein: Parkinson disease protein 7
- UniProt accession: Q99497
- Organism: Homo sapiens
- Variants analyzed: 392
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 262 unspecified-consequence records; 55 missense variants; 11 frameshift variants; 50 synonymous variants; 4 in-frame deletions; 7 splice-region variants; 3 stop-gained variants
- Prediction scores: 320 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Young adult-onset Parkinsonism, Parkinson disease, young-onset Parkinson disease, ulcerative colitis, inflammatory bowel disease, Crohn disease, amyotrophic lateral sclerosis-parkinsonism-dementia complex, peritonsillar abscess, sclerosing cholangitis, psoriasis, ankylosing spondylitis, neurodegenerative disease.
Protein structure and variant hotspots
- Protein features: 5 post-translational modification sites.
- PTM context: 10 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable PARK7 variants
Examples include A2S, A2T, A2D, A2V, A2A, S3F, S3Y, S3S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2S (p.Ala2Ser), gnomAD 1-7962789-G-T, REVEL 0.33, CADD 23.20
- A2T (p.Ala2Thr), gnomAD 1-7962789-G-A, REVEL 0.30, CADD 24.50
- A2D (p.Ala2Asp), gnomAD 1-7962790-C-A, REVEL 0.35, CADD 23.80
- A2V (p.Ala2Val), gnomAD 1-7962790-C-T, REVEL 0.19, CADD 24.20
- A2A (p.Ala2Ala), rs1050825335, gnomAD 1-7962791-T-C, CADD 14.90
- S3F (p.Ser3Phe), gnomAD 1-7962790-C-CT, CADD 29.70
- S3Y (p.Ser3Tyr), gnomAD 1-7962793-C-A, REVEL 0.47, CADD 26.20
- S3S (p.Ser3Ser), gnomAD 1-7962794-C-T, CADD 6.57
- K4E (p.Lys4Glu), TOPMed rs1490669574, gnomAD rs1490669574, REVEL 0.77, CADD 31.00
- K4N (p.Lys4Asn), cosmic curated COSV10465
- K4R (p.Lys4Arg), 1000Genomes rs190738218, ExAC rs190738218, TOPMed rs190738218, gnomAD rs190738218, REVEL 0.57, CADD 25.10
- K4Q (p.Lys4Gln), gnomAD 1-7962795-A-C, REVEL 0.71, CADD 29.10
- R5G (p.Arg5Gly), gnomAD rs1640236965, REVEL 0.60, CADD 23.50
- R5K (p.Arg5Lys), NCI-TCGA TCGA novel, REVEL 0.29, CADD 22.80, Variant assessed as somatic; moderate impact.
- R5I (p.Arg5Ile), gnomAD 1-7962799-G-T, REVEL 0.68, CADD 26.70
- A6D (p.Ala6Asp), ExAC rs773313843, TOPMed rs773313843, gnomAD rs773313843
- A6S (p.Ala6Ser), rs767539467, ClinGen CA569407, ClinVar RCV001313919, ExAC rs767539467, REVEL 0.84, CADD 28.70, Uncertain significance, Autosomal recessive early-onset Parkinson disease 7
- A6V (p.Ala6Val), ExAC rs773313843, TOPMed rs773313843, gnomAD rs773313843, REVEL 0.58, CADD 27.10
- A6P (p.Ala6Pro), gnomAD 1-7962801-G-C, REVEL 0.91, CADD 31.00
- A6A (p.Ala6Ala), gnomAD 1-7962803-T-C, CADD 12.80
- L7V (p.Leu7Val), Ensembl rs1640237155, REVEL 0.66, CADD 23.50
- L7R (p.Leu7Arg), gnomAD 1-7962805-T-G, REVEL 0.88, CADD 32.00
- L7L (p.Leu7Leu), gnomAD 1-7962806-G-A, CADD 13.30
- V8A (p.Val8Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V8I (p.Val8Ile), cosmic curated COSV10744
- V8E (p.Val8Glu), gnomAD 1-7962805-T-TAGAG, CADD 31.00
- V8V (p.Val8Val), gnomAD 1-7962809-C-A, CADD 13.20
- I9V (p.Ile9Val), gnomAD rs1640237235, REVEL 0.26, CADD 22.70
- I9I (p.Ile9Ile), rs1418453283, gnomAD 1-7962812-C-T, CADD 14.80
- L10M (p.Leu10Met), TOPMed rs1309873819, gnomAD rs1309873819, REVEL 0.65, CADD 25.30, Uncertain significance, in PARK7
- L10P (p.Leu10Pro), Ensembl rs1553122735, UniProt VAR 084339, Uncertain significance, in PARK7
- L10V (p.Leu10Val), rs1309873819, ClinGen CA338163926, ClinVar RCV000797024, TOPMed rs1309873819, REVEL 0.51, CADD 23.10, Uncertain significance, Autosomal recessive early-onset Parkinson disease 7
- L10L (p.Leu10Leu), gnomAD 1-7962813-C-T, CADD 13.90
- A11G (p.Ala11Gly), gnomAD rs1640237604, REVEL 0.54, CADD 24.70
- A11T (p.Ala11Thr), gnomAD rs1640237489, REVEL 0.57, CADD 27.20
- A11V (p.Ala11Val), gnomAD 1-7962817-C-T, REVEL 0.65, CADD 28.10
- A11A (p.Ala11Ala), rs1578089691, gnomAD 1-7962818-T-C, CADD 12.10
- K12E (p.Lys12Glu), gnomAD rs1385080898, REVEL 0.40, CADD 22.20
- K12R (p.Lys12Arg), gnomAD 1-7962820-A-G, REVEL 0.30, CADD 22.80
- K12N (p.Lys12Asn), gnomAD 1-7962821-A-C, REVEL 0.22, CADD 22.50
- G13E (p.Gly13Glu), gnomAD rs1353830065, REVEL 0.93, CADD 30.00
- A14T (p.Ala14Thr), ExAC rs761107607, TOPMed rs761107607, gnomAD rs761107607, REVEL 0.41, CADD 23.80
- A14G (p.Ala14Gly), gnomAD 1-7962826-C-G, REVEL 0.57, MetaLR 0.53
- A14A (p.Ala14Ala), rs1640237863, gnomAD 1-7962827-A-G, CADD 5.76
- E15* (p.Glu15Ter), Ensembl rs2151427246
- E15K (p.Glu15Lys), cosmic curated COSV58579, REVEL 0.84, CADD 32.00
- E15E (p.Glu15Glu), rs1298759249, gnomAD 1-7962830-G-A, CADD 13.10
- E16G (p.Glu16Gly), gnomAD rs1372795965, REVEL 0.85, CADD 32.00
- E16K (p.Glu16Lys), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- E16E (p.Glu16Glu), rs771692484, gnomAD 1-7962833-A-G, CADD 12.80
- M17I (p.Met17Ile), gnomAD rs1351385238, REVEL 0.51, CADD 23.30
- M17L (p.Met17Leu), 1000Genomes rs147698459, ESP rs147698459, ExAC rs147698459, TOPMed rs147698459, REVEL 0.49, CADD 24.10
- M17V (p.Met17Val), 1000Genomes rs147698459, ESP rs147698459, ExAC rs147698459, TOPMed rs147698459, REVEL 0.63, CADD 23.80
- E18D (p.Glu18Asp), ExAC rs752342660, TOPMed rs752342660, gnomAD rs752342660, REVEL 0.73, CADD 25.40, Likely benign
- E18G (p.Glu18Gly), Ensembl rs2151427256
- E18K (p.Glu18Lys), ExAC rs764771957, gnomAD rs764771957, REVEL 0.91, CADD 32.00
- E18E (p.Glu18Glu), rs752342660, gnomAD 1-7962839-G-A, CADD 13.40
- T19A (p.Thr19Ala), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- T19M (p.Thr19Met), rs758016497, ClinGen CA569415, NCI-TCGA Cosmic COSV5858, cosmic curated COSV58580, REVEL 0.51, CADD 23.20, Uncertain significance, Autosomal recessive early-onset Parkinson disease 7
- T19T (p.Thr19Thr), rs777350692, gnomAD 1-7962842-G-T, CADD 1.85
- V20A (p.Val20Ala), rs370430693, ClinGen CA569417, ClinVar RCV000367784, ESP rs370430693, REVEL 0.69, CADD 25.20, Uncertain significance, Autosomal recessive early-onset Parkinson disease 7
- V20D (p.Val20Asp), cosmic curated COSV58580
- V20I (p.Val20Ile), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, REVEL 0.23, CADD 22.70, Variant assessed as somatic; moderate impact.
- V20V (p.Val20Val), gnomAD 1-7962845-C-T, CADD 13.20
- I21T (p.Ile21Thr), Ensembl rs2151427269
- I21I (p.Ile21Ile), gnomAD 1-7962848-C-T, CADD 11.10
- P22L (p.Pro22Leu), Ensembl rs1640238691
- P22H (p.Pro22His), gnomAD 1-7962850-C-A, REVEL 0.84, MetaLR 0.80
- P22P (p.Pro22Pro), gnomAD 1-7962851-T-C, CADD 7.71
- V23I (p.Val23Ile), rs757247182, ClinGen CA569418, ClinVar RCV000993894, ExAC rs757247182, REVEL 0.28, CADD 22.70, Uncertain significance, not provided
- V23A (p.Val23Ala), gnomAD 1-7962853-T-C, REVEL 0.44, MetaLR 0.33
- V23V (p.Val23Val), gnomAD 1-7962854-A-T, CADD 12.30
- p.Asp24 Ala29del, gnomAD 1-7962853-TAGATGT, CADD 22.30
- V25I (p.Val25Ile), rs781346135, ClinGen CA569419, ClinVar RCV000395718, ClinVar RCV005452976, REVEL 0.15, CADD 19.90, Uncertain significance, Inborn genetic diseases; Autosomal recessive early-onset Parkinson disease 7
- V25V (p.Val25Val), rs745618719, gnomAD 1-7962860-C-T, CADD 13.10
- M26I (p.Met26Ile), rs74315351, ClinGen CA254092, cosmic curated COSV58580, ClinVar RCV000007481, AlphaMissense 0.92, MetaLR 0.36, Pathogenic, Autosomal recessive early-onset Parkinson disease 7
- M26L (p.Met26Leu), TOPMed rs1417802320, gnomAD rs1417802320, REVEL 0.41, CADD 21.10
- M26V (p.Met26Val), TOPMed rs1417802320, gnomAD rs1417802320, REVEL 0.57, CADD 23.70
- M26T (p.Met26Thr), gnomAD 1-7962862-T-C, REVEL 0.80, MetaLR 0.48
- R27G (p.Arg27Gly), cosmic curated COSV58580, REVEL 0.77, CADD 26.40
- R27K (p.Arg27Lys), ExAC rs769681126, gnomAD rs769681126, REVEL 0.47, CADD 25.60
- R28* (p.Arg28Ter), rs374429170, ClinGen CA17283697, ClinVar RCV001893894, ESP rs374429170, CADD 40.00, Pathogenic
- R28Q (p.Arg28Gln), rs142405016, ClinGen CA569423, cosmic curated COSV10009, ClinVar RCV001771782, REVEL 0.83, CADD 32.00, Likely pathogenic, Autosomal recessive early-onset Parkinson disease 7
- R28R (p.Arg28Arg), rs374429170, gnomAD 1-7962867-C-A, CADD 13.90
- A29G (p.Ala29Gly), ESP rs376428939, ExAC rs376428939, TOPMed rs376428939, gnomAD rs376428939, REVEL 0.36, CADD 23.60
- A29T (p.Ala29Thr), cosmic curated COSV10009
- A29V (p.Ala29Val), ESP rs376428939, ExAC rs376428939, TOPMed rs376428939, gnomAD rs376428939, REVEL 0.75, CADD 31.00
- A29A (p.Ala29Ala), gnomAD 1-7962872-T-A, CADD 12.00
- G30W (p.Gly30Trp), gnomAD 1-7962870-G-GC, CADD 33.00
- G30G (p.Gly30Gly), gnomAD 1-7962875-G-A, CADD 20.00
- I31F (p.Ile31Phe), ExAC rs749054218, gnomAD rs749054218, REVEL 0.47, CADD 24.20, Uncertain significance
- I31V (p.Ile31Val), rs749054218, ClinGen CA338164553, ClinVar RCV001097593, ExAC rs749054218, REVEL 0.25, CADD 16.30, Uncertain significance, Autosomal recessive early-onset Parkinson disease 7
- I31N (p.Ile31Asn), gnomAD 1-7962875-G-GA, CADD 34.00
- I31I (p.Ile31Ile), gnomAD 1-7965326-T-A, CADD 8.41
- K32E (p.Lys32Glu), gnomAD 1-7965327-A-G, REVEL 0.31, MetaLR 0.16
- K32K (p.Lys32Lys), rs1640301189, gnomAD 1-7965329-G-A, CADD 6.13
- V33L (p.Val33Leu), Ensembl rs2151428659
- T34I (p.Thr34Ile), rs772272696, ClinGen CA569442, ClinVar RCV000993895, ClinVar RCV001097594, REVEL 0.25, CADD 17.20, Uncertain significance, Autosomal recessive early-onset Parkinson disease 7; not provided
- T34T (p.Thr34Thr), rs374236728, gnomAD 1-7965335-C-G, CADD 0.74, SIFT 0.12
- V35I (p.Val35Ile), rs770946447, ClinGen CA569445, ClinVar RCV002909615, ClinVar RCV005002901, REVEL 0.11, CADD 0.01, Uncertain significance, Autosomal recessive early-onset Parkinson disease 7; not provided
- A36E (p.Ala36Glu), gnomAD rs1006337652
- A36V (p.Ala36Val), gnomAD rs1006337652, REVEL 0.49, CADD 25.60
- A36C (p.Ala36Cys), rs781600849, gnomAD 1-7965336-G-GT, CADD 25.10
- A36T (p.Ala36Thr), gnomAD 1-7965339-G-A, REVEL 0.66, MetaLR 0.71
- A36A (p.Ala36Ala), gnomAD 1-7965341-A-G, CADD 4.45, SIFT 0.38
- G37C (p.Gly37Cys), gnomAD 1-7965342-G-T, REVEL 0.71, MetaLR 0.65
- G37D (p.Gly37Asp), gnomAD 1-7965343-G-A, REVEL 0.72, MetaLR 0.56
- L38P (p.Leu38Pro), gnomAD rs1640301661, REVEL 0.84, CADD 28.30
- L38V (p.Leu38Val), TOPMed rs1640301603, REVEL 0.38, CADD 10.80
- L38* (p.Leu38Ter), gnomAD 1-7965343-G-GGTGA, CADD 33.00
- L38M (p.Leu38Met), gnomAD 1-7965345-C-A, REVEL 0.48, MetaLR 0.51
- A39S (p.Ala39Ser), rs137853051, ClinGen CA254098, ClinVar RCV000007485, UniProt VAR 072589, AlphaMissense 0.08, MetaLR 0.13, Pathogenic, Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1
- A39T (p.Ala39Thr), TOPMed rs137853051, Pathogenic, found in early-onset Parkinson disease with digenic inheritance
- A39L (p.Ala39Leu), gnomAD 1-7965346-TG-T, CADD 27.80
- p.Ala39 Gly40del, gnomAD 1-7965346-TGGCTGG, CADD 21.40
- K41E (p.Lys41Glu), gnomAD 1-7965354-A-G, REVEL 0.34, MetaLR 0.21
- K41K (p.Lys41Lys), gnomAD 1-7965356-A-G, CADD 8.30, SIFT 0.78
- D42A (p.Asp42Ala), TOPMed rs1234524912, gnomAD rs1234524912
- D42E (p.Asp42Glu), gnomAD rs1337083012, REVEL 0.25, CADD 13.80
- D42V (p.Asp42Val), TOPMed rs1234524912, gnomAD rs1234524912, REVEL 0.35, CADD 23.30
- D42H (p.Asp42His), gnomAD 1-7965357-G-C, REVEL 0.33, MetaLR 0.42
- P43Q (p.Pro43Gln), gnomAD rs1640301985, REVEL 0.50, CADD 25.90
- P43R (p.Pro43Arg), gnomAD 1-7965361-C-G, REVEL 0.57, MetaLR 0.46
- P43P (p.Pro43Pro), rs1006233556, gnomAD 1-7965362-A-G, CADD 3.61, SIFT 0.04
- V44A (p.Val44Ala), TOPMed rs1340110901, gnomAD rs1340110901, REVEL 0.76, CADD 27.50
- V44L (p.Val44Leu), TOPMed rs1640302275, REVEL 0.71, CADD 26.30
- V44I (p.Val44Ile), gnomAD 1-7965363-G-A, REVEL 0.38, MetaLR 0.48
- V44V (p.Val44Val), rs1014727907, gnomAD 1-7965365-A-G, CADD 5.57, SIFT 0.00
- Q45* (p.Gln45Ter), rs1553122918, ClinGen CA338164712, ClinVar RCV001095538, Ensembl rs1553122918, Pathogenic, in PARK7
- Q45H (p.Gln45His), ExAC rs776602132, TOPMed rs776602132, gnomAD rs776602132, REVEL 0.18, CADD 22.90
- Q45K (p.Gln45Lys), cosmic curated COSV58579, REVEL 0.26, CADD 17.80
- Q45R (p.Gln45Arg), gnomAD 1-7965367-A-G, REVEL 0.33, MetaLR 0.18
- Q45Q (p.Gln45Gln), rs776602132, gnomAD 1-7965368-G-A, CADD 9.93, SIFT 0.00
- C46R (p.Cys46Arg), TOPMed rs1490232637
- C46G (p.Cys46Gly), gnomAD 1-7965369-T-G, REVEL 0.60, MetaLR 0.35
- S47G (p.Ser47Gly), TOPMed rs1015407444, gnomAD rs1015407444, REVEL 0.75, CADD 27.30
- S47R (p.Ser47Arg), rs2527325021, ClinGen CA338164753, ClinVar RCV004502549, cosmic curated COSV10465, REVEL 0.59, CADD 24.30, Uncertain significance, Inborn genetic diseases
- R48C (p.Arg48Cys), rs760020407, ClinGen CA569447, ClinVar RCV002629932, ExAC rs760020407, REVEL 0.63, CADD 28.90, Uncertain significance, Autosomal recessive early-onset Parkinson disease 7
- R48G (p.Arg48Gly), ExAC rs760020407, TOPMed rs760020407, gnomAD rs760020407, Uncertain significance
- R48H (p.Arg48His), rs145727915, cosmic curated COSV58579, ESP rs145727915, ExAC rs145727915, REVEL 0.48, CADD 29.60, Variant assessed as somatic; moderate impact.
- R48R (p.Arg48Arg), gnomAD 1-7965377-T-G, CADD 11.10
- D49Y (p.Asp49Tyr), gnomAD 1-7965378-G-T, REVEL 0.63, MetaLR 0.77
- V50L (p.Val50Leu), gnomAD rs1640303219, REVEL 0.42, CADD 23.20
- V50A (p.Val50Ala), gnomAD 1-7965382-T-C, REVEL 0.50, MetaLR 0.36
- V51G (p.Val51Gly), Ensembl rs1578091869
- V51I (p.Val51Ile), gnomAD 1-7965384-G-A, REVEL 0.06, MetaLR 0.18
- I52V (p.Ile52Val), cosmic curated COSV58579, ExAC rs775909660, gnomAD rs775909660, REVEL 0.36, CADD 20.70
- C53F (p.Cys53Phe), gnomAD rs1186457000, REVEL 0.49, CADD 23.10
- C53W (p.Cys53Trp), ExAC rs763477392, gnomAD rs763477392
- C53Y (p.Cys53Tyr), gnomAD 1-7965391-G-A, REVEL 0.46, MetaLR 0.34
- P54A (p.Pro54Ala), NCI-TCGA Cosmic COSV5858, cosmic curated COSV58580, Variant assessed as somatic; moderate impact.
- P54H (p.Pro54His), ESP rs368405677, TOPMed rs368405677, gnomAD rs368405677, REVEL 0.82, CADD 26.40
- P54S (p.Pro54Ser), TOPMed rs1372486544
- A56T (p.Ala56Thr), rs114601558, ClinGen CA569451, ClinVar RCV000873564, ClinVar RCV002064736, REVEL 0.06, CADD 15.50, Benign/Likely benign, not specified; Autosomal recessive early-onset Parkinson disease 7; not provided
- A56V (p.Ala56Val), rs2527325118, ClinGen CA338164871, ClinVar RCV002940649, REVEL 0.10, CADD 21.60, Uncertain significance, Inborn genetic diseases
- S57I (p.Ser57Ile), TOPMed rs1418733118, gnomAD rs1418733118, REVEL 0.68, CADD 27.80
- S57T (p.Ser57Thr), TOPMed rs1418733118, gnomAD rs1418733118, REVEL 0.32, CADD 23.30
- S57S (p.Ser57Ser), rs1640303863, gnomAD 1-7965404-C-T, CADD 10.20
- L58V (p.Leu58Val), cosmic curated COSV58580
- E59D (p.Glu59Asp), ExAC rs751305698, TOPMed rs751305698, gnomAD rs751305698, REVEL 0.42, CADD 20.20
- E59Q (p.Glu59Gln), cosmic curated COSV58580
- D60A (p.Asp60Ala), gnomAD 1-7965412-A-C, REVEL 0.36, MetaLR 0.43
- D60V (p.Asp60Val), gnomAD 1-7965412-A-T, REVEL 0.60, MetaLR 0.61
- A61E (p.Ala61Glu), cosmic curated COSV10465, gnomAD rs1449957205
- A61T (p.Ala61Thr), ExAC rs761582953, gnomAD rs761582953, REVEL 0.39, CADD 29.20
- A61V (p.Ala61Val), gnomAD rs1449957205, REVEL 0.28, CADD 22.90
- A61S (p.Ala61Ser), gnomAD 1-7965414-G-T, REVEL 0.49, MetaLR 0.54
- A61G (p.Ala61Gly), gnomAD 1-7965415-C-G, REVEL 0.41, MetaLR 0.49
- K63R (p.Lys63Arg), ExAC rs767015117, gnomAD rs767015117, REVEL 0.26, CADD 22.90
- K63T (p.Lys63Thr), gnomAD 1-7965421-A-C, REVEL 0.16, MetaLR 0.25
- K63K (p.Lys63Lys), gnomAD 1-7965422-A-G, CADD 10.60
- E64D (p.Glu64Asp), rs74315353, ClinGen CA254096, ClinVar RCV000007483, UniProt VAR 020493, REVEL 0.36, CADD 34.00, Pathogenic, Autosomal recessive early-onset Parkinson disease 7
- E64Q (p.Glu64Gln), Ensembl rs1640304434, REVEL 0.21, CADD 16.00
- E64R (p.Glu64Arg), rs759703272, gnomAD 1-7965415-CA-C, CADD 24.40
- E64G (p.Glu64Gly), gnomAD 1-7965424-A-G, REVEL 0.33, MetaLR 0.33
- E64E (p.Glu64Glu), gnomAD 1-7965425-G-A, CADD 26.70
- G65R (p.Gly65Arg), Ensembl rs1640402009, REVEL 0.46, CADD 26.00
- G65V (p.Gly65Val), gnomAD rs1370609204, REVEL 0.47, CADD 24.70
- G65G (p.Gly65Gly), rs1232551667, gnomAD 1-7969347-A-T, CADD 11.60, SIFT 0.09
- P66Q (p.Pro66Gln), TOPMed rs1306142962, gnomAD rs1306142962, REVEL 0.47, CADD 22.60
Public PARK7 analysis runs
- PARK7 analysis run — PARK7 (392 variants) — completed 2026-08-18